ArticleJournal of autism and developmental disorders2025
Psychotropic Medication Use in Children and Youth with Autism Enrolled in Medicaid.
Article in Journal of autism and developmental disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 24 citations in OpenAlex.
- Exploring Psychotropic Medication Use in Hospitalized Children With Autism Spectrum Disorder in China: The Role of Intellectual Disability.Journal of autism and developmental disorders · 2026Article
- Therapy and Antidepressant Use in 8- to 29-Year-Old Autistic Medicaid Enrollees With Depression.Autism : the international journal of research and practice · 2026Article
- Parental Acceptance and Understanding of Autistic Children (PAUACS) - an Instrument Development Study.Journal of autism and developmental disorders · 2026Article
- Brief Report: Healthcare Utilization and Expenditure Trends Among Autistic Transition Age Youth.Journal of autism and developmental disorders · 2026Article
- Antipsychotic Drug Prescriptions for Transition-Age Youth on the Autism Spectrum.Journal of autism and developmental disorders · 2026Article
- Behavioral Sleep Interventions for Neurodivergent Youth: A Narrative Review.Current sleep medicine reports · 2026Review
- A Rapid Mapping Review of Medication Burden in Adults with an Intellectual Disability: What We Know and What We Do Not Know.Drug, healthcare and patient safety · 2026Review
- Utilization of psychotropic medications in individuals with autism spectrum disorder.BMC psychiatry · 2025Article
- A Longitudinal Transdisciplinary Approach for Autism Spectrum Disorder.Children (Basel, Switzerland) · 2025Article
- Association between autism spectrum disorder and intentional self-harm.Injury epidemiology · 2025Article
- "They Showed Me How to Improve My Drawings and That Made Me Happy": A Realist Evaluation of a Digital Arts Multimedia Program for Autistic Adolescents.Journal of autism and developmental disorders · 2025Article
- Prescriptions for Antipsychotics: Youth with Intellectual/Developmental Disabilities Compared to Youth without Intellectual/Developmental Disabilities.Journal of autism and developmental disorders · 2025Article
- Sociodemographic Factors Associated with Autistic Youth's Psychotherapy Service Use.Administration and policy in mental health · 2025Article
- Social Skills Through an Autistic Lens: A Qualitative Analysis of Young Adults' Insights and Experiences.Journal of autism and developmental disorders · 2025Article
- Pubertal developmental, body mass index, and cardiovascular autonomic function in children and adolescents with and without autism spectrum disorder: a four-time point accelerated longitudinal study.Journal of neurodevelopmental disorders · 2025Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 4 institutions in 2 countries.
Funding
Abstract
Children with autism frequently present with complex mental health diagnoses and psychotropic medications are often a component of comprehensive biopsychosocial treatment plans for these conditions. The purpose of this study is to provide rates and patterns of psychotropic medication use, and predictors thereof, in children and youth with autism enrolled in Medicaid across the US. This study examined national Medicaid claims from 2008 to 2016 of all children and youth with autism ages 0-21 years enrolled in Medicaid. Psychotropic medication use was examined across several child and youth characteristics, including age, co-occurring mental health conditions, sex, and race and ethnicity. About half of children and youth with autism enrolled in Medicaid had at least one psychotropic prescription in a year, a number that decreased slightly across the study period due to decreases in the prescription of antipsychotics. As new medications for autism or co-occurring conditions are developed and deployed, and as the understanding of the characteristics of the population of children with autism evolves, studying rates of medication usage helps to understand utilization patterns and differences in access to quality care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.